Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 11INDUSTRY 5NIH 2OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 9Plasma cell 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 133Stomach Neoplasms 107Carcinoma, Hepatocellular 73Rectal Neoplasms 64Esophageal Neoplasms 53Pancreatic Neoplasms 52Colonic Neoplasms 52Neoplasms 28Neoplasm Metastasis 20Esophageal Squamous Cell Carcinoma 20Gastrointestinal Neoplasms 19Cholangiocarcinoma 14Liver Neoplasms 13Breast Neoplasms 13Barrett Esophagus 9Lung Neoplasms 8Adenoma 8Motor Activity 7Liver Cirrhosis 7Digestive System Neoplasms 7Colonic Polyps 7Adenomatous Polyposis Coli 7Biliary Tract Neoplasms 6Anastomotic Leak 6Sarcopenia 5Inflammatory Bowel Diseases 5Hypertension, Portal 5Gallbladder Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4

Interventions

spartalizumab 1Nivolumab 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Bone Neoplasms × Gastrointestinal × Clear all
NCT02982486 2017-11-01

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Assaf-Harofeh Medical Center

Phase 2 Unknown
60 enrolled
GastrointestinalSarcoma

Bone Neoplasms, Chondrosarcoma, Sarcoma, Osteosarcoma, Gastrointestinal Stromal Tumors, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡